跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
SKYTROFA lonapegsomatropin 5.2 mg powder and solvent for solution for injection dual chamber glass cartridge
Approved
STANDARD
SKYTROFA lonapegsomatropin 5.2 mg powder and solvent for solution for injection dual chamber glass cartridge
Specialised Therapeutics Pharma Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
de893fb2daefabfe
Company
Specialised Therapeutics Pharma Pty Ltd
Type
Standard
Approval Details
Approval Id
de893fb2daefabfe
Product Name
SKYTROFA lonapegsomatropin 5.2 mg powder and solvent for solution for injection dual chamber glass cartridge
Artg Id
445801
Artg Name
SKYTROFA lonapegsomatropin 5.2 mg powder and solvent for solution for injection dual chamber glass cartridge
Sponsor
Specialised Therapeutics Pharma Pty Ltd
Company Detail Path
/organization/specialised-therapeutics-pharma-pty-ltd
Artg Date
2025-05-23
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/ae730bb234cfa1588da39a8d9514e175.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/595f99a34abffa4f6e61ed4a49fc5a87.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
de893fb2daefabfe
Type
Standard
Back to TGA Approvals
SKYTROFA lonapegsomatropin 5.2 mg powder and solvent for solution for injection dual chamber glass cartridge - TGA Drug Approval Details